The student news site of The Harker School.

Harker Aquila

Menu
Biotechnology companies Pfizer, Moderna and AstraZeneca released first interim analysis reports from Phase 3 trials of their respective COVID-19 vaccines, all within the past month. The vaccines have efficacy rates of more than 95%, 94.5% and 70%, respectively.

3 COVID-19 vaccines move forward after promising Phase 3 clinical trial data

by Mark Hu and Sabrina Zhu • December 2, 2020

Biotechnology companies Pfizer, Moderna and AstraZeneca released first interim analysis reports from Phase 3 trials of their respective COVID-19 vaccines, all within the past month. The vaccines have efficacy...

Load More Stories
Activate Search
The student news site of The Harker School.
Vasudha Subramanian